Disclosed is a particulate pharmaceutical composition for oral administration, which is obtained by coating particles, which contain atorvastatin or a pharmaceutically acceptable salt thereof and sodium lauryl sulfate, with a coating material that contains a polyvinyl acetal diethylamino acetate and a water-soluble polymer material.